Biologics Market Scope And Analysis

  • Report Code : TIPRE00002765
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 200
Buy Now

Biologics Market Scope and Analysis Report by 2031

Buy Now

Biologics Market Report Biologics Market Size and Share Biologics Market Scope and Analysis

Biologics Market Report Scope

Report Attribute Details
Market size in 2023 US$ 469.2 Billion
Market Size by 2031 US$ 1,793.9 Billion
Global CAGR (2023 - 2031) 18.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Hormones/Proteins
  • Cell and Gene Therapies
By Application
  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
By Source
  • Mammalian
  • Microbial
By Manufacturing
  • Outsourced
  • In-House
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AbbVie Inc
  • Pfizer Inc
  • Samsung Biologics
  • ADMA Biologics Inc
  • WuXi Biologics
  • Catalent Inc
  • AGC Biologics
  • AstraZeneca
  • Amgen Inc
  • Avecia Biologics

    • Biologics Market News and Recent Developments

    The biologics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

    • Samsung Biologics, a global contract development and manufacturing organization (CDMO), announced a partnership agreement with LegoChem Biosciences, a biotech company pioneering the research and development of antibody-drug conjugate (ADC) programs. Under the terms of the deal, Samsung Biologics will provide antibody development and drug substance manufacturing services as a part of LegoChem Biosciences' ADC program designed to treat solid tumors. (Samsung Biologics, Press Release, February 2024)
    • Selvita S.A. announced a strategic initiative to significantly expand its services portfolio and enter the field of biologic drug discovery and development by adding comprehensive therapeutic antibody discovery and development capabilities to its portfolio. (Selvita, Press Release, March 2024)

    Biologics Market Report Coverage and Deliverables

    The "Biologics Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

    • Biologics market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Biologics market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter's Five Forces and SWOT analysis
    • Biologics market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the biologics market
    • Detailed company profiles